Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.41 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.41 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10510078 | 1.00 | HRH3 (0.49) | HRH3MEN1KMT2AL3MBTL1MAPT | |
| Hydroxyamine SCHEMBL1454400 | 0.98 | L3MBTL1 (0.50) | HRH3MEN1KMT2AL3MBTL1MAPT | |
| SCHEMBL3271095 | 0.97 | HRH3 (0.46) | HRH3MEN1KMT2AL3MBTL1MAPT | |
| SCHEMBL7388734 | 0.89 | HRH3 (0.53) | HRH3MEN1KMT2AL3MBTL1MAPT | |
| SCHEMBL9319178 | 0.87 | HRH3 (0.38) | HRH3KMT2ALMNASMN1; SMN2 | |
| SCHEMBL24724037 | 0.82 | HRH3 (0.48) | HRH3MAPTALDH1A1POLBCARM1 | |
| SCHEMBL12716 | 0.82 | HRH3 (0.48) | HRH3MAPTALDH1A1POLBCARM1 | |
| SCHEMBL18668199 | 0.82 | MEN1 (0.50) | HRH3MEN1KMT2AL3MBTL1MAPT | |
| SCHEMBL8074673 | 0.82 | HRH3 (0.48) | HRH3MAPTALDH1A1POLBCARM1 | |
| SCHEMBL21990873 | 0.82 | MEN1 (0.50) | HRH3MEN1KMT2AL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107083-A2 | SHELF-STABLE LOXSH CATALYST SOLUTION COMPOSITIONS COMPRISING SOLUBLE HIGH HYDRIDE CONCENTRATIONS AND THE PROCESSES FOR PREPARING THEM | ALBEMARLE CORPORATION (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4208485-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC POLYMERIZATION OF CONJUGATED DIENES AND LIQUID POLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-07-12 | — | — | EP | claimed |
| US-7910078-B2 | using an aminoalcohol derived from 4-amino-2-butanol, which have a higher CO2 absorption capacity; global warming; e.g. 4-(diethylamino)-2-butanol or 4-(piperidino)-2-butanol | UNIVERSITY OF REGINA (CA) | 2011-03-22 | — | — | US | claimed |
| US-20080050296-A1 | METHOD OF CAPTURING CARBON DIOXIDE FROM GAS STREAMS | UNIVERSITY OF REGINA (CA) | 2008-02-28 | — | — | US | claimed |
| WO-2026107083-A2 | SHELF-STABLE LOXSH CATALYST SOLUTION COMPOSITIONS COMPRISING SOLUBLE HIGH HYDRIDE CONCENTRATIONS AND THE PROCESSES FOR PREPARING THEM | ALBEMARLE CORPORATION (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4208485-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC POLYMERIZATION OF CONJUGATED DIENES AND LIQUID POLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-07-12 | — | — | EP | disclosed |
| US-20170348320-A1 | IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE | AMBIT BIOSCIENCES CORP (US) | 2017-12-07 | — | — | US | disclosed |
| US-20150126505-A1 | IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE | AMBIT BIOSCIENCES CORP (US) | 2015-05-07 | — | — | US | disclosed |
| US-8921546-B2 | Imidazolothiazole compounds for the treatment of disease | AMBIT BIOSCIENCES CORPORATION (US) | 2014-12-30 | — | — | US | disclosed |
| US-20140243525-A1 | IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE | AMBIT BIOSCIENCES CORPORATION (US) | 2014-08-28 | — | — | US | disclosed |
| US-8581178-B2 | Combined mass and differential mobility spectrometry and associated methods, systems, and devices | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2013-11-12 | — | — | US | disclosed |
| US-8557810-B2 | Imidazolothiazole compounds for the treatment of disease | AMBIT BIOSCIENCES CORPORATION (US) | 2013-10-15 | — | — | US | disclosed |
| US-20080050296-A1 | METHOD OF CAPTURING CARBON DIOXIDE FROM GAS STREAMS | UNIVERSITY OF REGINA (CA) | 2008-02-28 | — | — | US | disclosed |
| US-20080050296-A1 | METHOD OF CAPTURING CARBON DIOXIDE FROM GAS STREAMS | UNIVERSITY OF REGINA (CA) | 2008-02-28 | — | — | US | disclosed |
| US-20080050296-A1 | METHOD OF CAPTURING CARBON DIOXIDE FROM GAS STREAMS | UNIVERSITY OF REGINA (CA) | 2008-02-28 | — | — | US | disclosed |
| WO-2008022437-A1 | METHOD FOR CAPTURING CARBON DIOXIDE FROM GAS STREAMS | UNIVERSITY OF REGINA (CA) | 2008-02-28 | — | — | WO | disclosed |
| EP-1866294-A1 | COMPOUNDS COMPRISING AN OXAZOLINE OR THIAZOLINE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES | UCB Pharma, S.A. (BE) | 2007-12-19 | — | — | EP | disclosed |
| US-20060289745-A1 | Combined mass and differential mobility spectrometry and associated methods, systems, and devices | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2006-12-28 | — | — | US | disclosed |
| WO-2006103057-A1 | COMPOUNDS COMPRISING AN OXAZOLINE OR THIAZOLINE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES | UCB PHARMA, S.A. (BE) | 2006-10-05 | — | — | WO | disclosed |
| US-4992150-A | Telomer with alpha-olefin;oil and fuel additive | NIPPON OIL CO, LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126505-A1 | IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE | GRK2, GRK4, GRK3 | HRH3 647/4885MEN1 2844/4885KMT2A 2671/4885 |
| US-20140243525-A1 | IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE | GRK2, GRK4, GRK3 | HRH3 647/4885MEN1 2844/4885KMT2A 2671/4885 |
| US-20080050296-A1 | METHOD OF CAPTURING CARBON DIOXIDE FROM GAS STREAMS | ADH1C, ADH5, ADH1A | HRH3 228/4885MEN1 4156/4885KMT2A 2543/4885 |
| US-20170348320-A1 | IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE | GRK2, GRK4, GRK3 | HRH3 647/4885MEN1 2844/4885KMT2A 2671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.